Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online